Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov 26:11:594077.
doi: 10.3389/fpsyt.2020.594077. eCollection 2020.

Commentary: Psychedelic Psychiatry's Brave New World

Affiliations
Comment

Commentary: Psychedelic Psychiatry's Brave New World

Bénédicte Nobile et al. Front Psychiatry. .
No abstract available

Keywords: psilocybin; psychedelics; suicidal behavior; suicide; therapeutic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Nutt D, Erritzoe D, Carhart-Harris R. Psychedelic psychiatry's brave new world. Cell. (2020) 181:24–8. 10.1016/j.cell.2020.03.020 - DOI - PubMed
    1. Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, et al. . Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry. (2020) 177:391–410. 10.1176/appi.ajp.2019.19010035 - DOI - PubMed
    1. Courtet P, Nobile B. Inclusion of suicidal individuals in research studies. J Clin Psychiatry. (2020) 81:20com13276. 10.4088/JCP.20com13276 - DOI - PubMed
    1. Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. J Psychopharmacol. (2015) 29:280–88. 10.1177/0269881114565653 - DOI - PubMed
    1. Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, et al. . Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. (2018) 235:399–408. 10.1007/s00213-017-4771-x - DOI - PMC - PubMed

LinkOut - more resources